Cargando…
Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
Drug-eluting stents (DES) have had a major impact in interventional cardiology. Compared to bare metal stents, they significantly reduce restenosis and the need for target vessel revascularization. Four DES are available in the US, the first-generation sirolimus-eluting (Cypher(®)) and paclitaxel-el...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801632/ https://www.ncbi.nlm.nih.gov/pubmed/20057901 |